If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
LEXINGTON, Mass. & SAN FRANCISCO–(HSMN NewsFeed)–Antigenics Inc. (NASDAQ:AGEN ) today announced that the Brain Tumor Research Center at the University of California, San Francisco, has begun enrolling patients into a Phase 2 medical trial of Oncophage (…
Biopharmaceuticals, Oncology
Antigenics , Oncophage, vitespen, glioma
Posts on ‘August 12th, 2009’
Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics’ Oncophage(R) Cancer Vaccine in Newly Diagnosed Glioma
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharma Operations
BOTHELL, Wash., Aug 12–(HSMN NewsFeed)–Alder Biopharmaceuticals, Inc., an emerging antibody therapeutics company, today announced the appointment of Mark D. Young, Ph.D., as Senior Vice President of Pharmaceutical Operations. A veteran biotechnology i…
Biopharmaceuticals, Personnel
Alder Biopharmaceuticals
Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device
CardioVasc Advantage(TM) Vascular Reconstruction Device now cleared for marketing in Europe PALO ALTO, Calif., Aug. 12 (HSMN NewsFeed) — Nfocus Neuromedical Inc. announced today that its CardioVasc Advantage(TM) Vascular Reconstruction Device has bee…
Devices, Interventional, Regulatory
Nfocus Neuromedical, CardioVasc Advantage, Vascular Reconstruction
NiTi Surgical Solutions Secures $18.5 Million in Series F Financing
Company Leading Innovation in Colorectal Surgery CHESTERFIELD, Mo. & NETANIA, Israel–(HSMN NewsFeed)–NiTi(TM) Surgical Solutions, an innovative surgical device company, today announced the completion of a financing round, in which the company raised a…
Devices, Surgery, Venture Capital
NiTi Surgical Solutions, ColonRing
